Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug

Goodman and Gilman's The Pharmacological Basis of Therapeutics

Hastings, R. C. (1996) · JAMA · doi:10.1001/jama.1996.03540120077042 · Cited by 2,375

Determination of subcutaneous tumor size in athymic (nude) mice

Tomayko, M. M., & Reynolds, C. P. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00300234 · Cited by 1,830

Cancer: Principles and Practice of Oncology

Gunn, W. G. (1994) · JAMA · doi:10.1001/jama.1994.03510350091047 · Cited by 1,803

Inhibition of NF-κB by Sodium Salicylate and Aspirin

Kopp, E. B., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,744

Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins

Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,111

Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B

Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742

NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis

Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 594

Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion

Back, S. A., Gan, X., Li, Y., Rosenberg, P. A., & Volpe, J. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06241.1998 · Cited by 586

Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

Bannai, S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35926-4 · Cited by 549

Analgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout

Insel, P. (1996) · Medical Entomology and Zoology · Cited by 416

Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases

You, H., Wang, L., Bu, F., Meng, H., Huang, C., Fang, G.-Y., & Li, J. (2022) · Cells · doi:10.3390/cells11203301 · Cited by 33

Targeting fatty acid uptake and metabolism in cancer cells: A promising strategy for cancer treatment

Mallick, R., Bhowmik, P., & Duttaroy, A. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115591 · Cited by 35

A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis

Wang, L., Huang, H., Li, X., Ouyang, L., Wei, X., Xie, J., Liu, D., Tan, P., & Hu, Z. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00838-1 · Cited by 34

Ferroptosis: Redox Imbalance and Hematological Tumorigenesis

Lan, H., Gao, Y., Zhao, Z., Mei, Z., & Wang, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.834681 · Cited by 34

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

Nashed, M. G., Ungard, R. G., Young, K., Zacal, N., Seidlitz, E. P., Fazzari, J., Frey, B. N., & Singh, G. (2017) · Scientific Reports · doi:10.1038/srep41382 · Cited by 32

New insights into redox homeostasis as a therapeutic target in B-cell malignancies

Graczyk-Jarzynka, A., Zagozdzon, R., Muchowicz, A., Siernicka, M., Juszczynski, P., & Firczuk, M. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000351 · Cited by 29

Mechanisms of ferroptosis in hypoxic-ischemic brain damage in neonatal rats

Zheng, J., Yu, F., Zhang, M., Gao, Q., Li, J., Yuan, H., Jin, W., Lin, Z., & Lin, W. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114641 · Cited by 29

xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells

Zhang, P., Wang, W., WEI, Z., Li, X., YANG, X., & Du, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4571 · Cited by 29

Identification of capsazepine as a novel inhibitor of system xc− and cancer-induced bone pain

Fazzari, J., Balenko, M. D., Zacal, N., & Singh, G. (2017) · Journal of Pain Research · doi:10.2147/jpr.s125045 · Cited by 29

Revisiting Tumors and the Cardiovascular System: Mechanistic Intersections and Divergences in Ferroptosis

Wang, Y., Peng, X., Zhang, M., Jia, Y., Yu, B., & Tian, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9738143 · Cited by 30

Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies

Magri, J., Gasparetto, A., Conti, L., Calautti, E., Cossu, C., Ruiu, R., Barutello, G., & Cavallo, F. (2021) · Cells · doi:10.3390/cells10010108 · Cited by 31

Current progress of ferroptosis study in ovarian cancer

Tan, Z., Huang, H., Sun, W., Li, Y., & Jia, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.966007 · Cited by 29

Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases

Costa, I. D., Barbosa, D. J., Silva, V., Benfeito, S., Borges, F., Remião, F., & Silva, R. V. D. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051369 · Cited by 30

Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer

Wang, S., Chang, Y., Fang, W., Li, A. F., Chen, C., Yeh, T., Hung, G., Huang, K., & Lee, H. (2023) · Cancer Science · doi:10.1111/cas.15869 · Cited by 28

Mitochondrial Regulation of Ferroptosis in Cancer Therapy

Cheng, X., Zhang, J., Xiao, Y., Wang, Z., He, J., Ke, M., Liu, S., Wang, Q., & Zhang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210037 · Cited by 29

Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration

Wolf, I. M. L., Fan, Z., Rauh, M., Seufert, S., Hore, N., Buchfelder, M., Savaskan, N. E., & Eyüpoglu, I. Y. (2014) · Scientific Reports · doi:10.1038/srep06226 · Cited by 29

Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects

Okazaki, F., Matsunaga, N., Hamamura, K., Suzuki, K., Nakao, T., Okazaki, H., Kutsukake, M., Fukumori, S., Tsuji, Y., & To, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0720 · Cited by 29

DDIT4 promotes malignancy of head and neck squamous cell carcinoma

Zhang, Z., Zhu, H., Zhao, C., Liu, D., Luo, J., Ying, Y., & Zhong, Y. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23489 · Cited by 28

Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality

Hagiwara, M., Kikuchi, E., Kosaka, T., Mikami, S., Saya, H., & Oya, M. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.03.015 · Cited by 29

Anti-tumor effect of sulfasalazine in neuroblastoma

Mooney, M. R., Geerts, D., Kort, E. J., & Bachmann, A. S. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.007 · Cited by 28

Exploring Amino Acid Transporters as Therapeutic Targets for Cancer: An Examination of Inhibitor Structures, Selectivity Issues, and Discovery Approaches

Jakobsen, S., & Nielsen, C. U. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020197 · Cited by 28

Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL

Bian, W., Li, H., Chen, Y., Yu, Y., Lei, G., Yang, X., Li, S., Chen, X., Li, Y., Yang, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116386 · Cited by 28

N-Acetylcysteine causes analgesia in a mouse model of painful diabetic neuropathy

Notartomaso, S., Scarselli, P., Mascio, G., Liberatore, F., Mazzon, E., Mammana, S., Gugliandolo, A., Cruccu, G., Bruno, V., Nicoletti, F., et al. (2020) · Molecular Pain · doi:10.1177/1744806920904292 · Cited by 28

Cysteine Boosts Fitness Under Hypoxia-Mimicked Conditions in Ovarian Cancer by Metabolic Reprogramming

Nunes, S. C., Ramos, C., Santos, I. P., Mendes, C., SILVA, F. A. B. N. D., Vicente, J. B., Pereira, S. A., Félix, A., Gonçalves, L. G., & Serpa, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722412 · Cited by 28

Cysteine Metabolism in Tumor Redox Homeostasis

Fan, Y., Tan, X., Zhao, H., Tu, X., Liu, X., & Wang, Y. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220817141227 · Cited by 27

Ferroptosis: a potential therapeutic target for Alzheimer’s disease

Yang, L., & Nao, J. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0121 · Cited by 28

Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT‐targeted therapy

Otsuki, Y., Yamasaki, J., Suina, K., Okazaki, S., Koike, N., Saya, H., & Nagano, O. (2019) · Cancer Science · doi:10.1111/cas.14224 · Cited by 27

The deubiquitinase ZRANB1 is an E3 ubiquitin ligase for SLC7A11 and regulates ferroptotic resistance

Huang, S., Zhang, Q.-M., Zhao, M., Wang, X., Zhang, Y., Gan, B., & Zhang, P. (2023) · The Journal of Cell Biology · doi:10.1083/jcb.202212072 · Cited by 26

Ferroptosis, Metabolic Rewiring, and Endometrial Cancer

Žalytė, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010075 · Cited by 29

Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs

Yang, L., Liu, Y., Zhang, N., Ding, X., Zhang, W., Shen, K., Huang, L., Zhou, J., Cui, S., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16449 · Cited by 28

System xc− in microglia is a novel therapeutic target for post-septic neurological and psychiatric illness

Kitagawa, Y., Nakaso, K., Horikoshi, Y., Morimoto, M., Omotani, T., Otsuki, A., Inagaki, Y., Sato, H., & Matsura, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-44006-8 · Cited by 28

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative

Carbone, L. D., Vasan, S., Elam, R. E., Gupta, S. J., Tolaymat, O., Crandall, C. J., Wactawski‐Wende, J., & Johnson, K. (2020) · JBMR Plus · doi:10.1002/jbm4.10393 · Cited by 26

Opportunities for Ferroptosis in Cancer Therapy

Fujihara, K. M., Zhang, B. Z., & Clemons, N. J. (2021) · Antioxidants · doi:10.3390/antiox10060986 · Cited by 27

Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response

Garcia, C. G., Kahn, S. A., Geraldo, L. H., Romano, I., Domith, I., Silva, D. C. L. E., Assunção, F. D. S., Ferreira, M. J., Portugal, C. C., de Souza, J. M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0895-1 · Cited by 26

Molecular Mechanisms of Ferroptosis and Its Role in Viral Pathogenesis

Huang, R.-W., Wu, J., Ma, Y., & Kang, K. (2023) · Viruses · doi:10.3390/v15122373 · Cited by 26

SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance

Li, T.-Z. (2024) · American Journal of Cancer Research · doi:10.62347/kgcl7357 · Cited by 25

Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism

Olivo, E., Chimia, M. L., Ceramella, J., Catalano, A. A., Chiaradonna, F., Sinicropi, M. S., Cuda, G., Iacopetta, D., & Scumaci, D. (2022) · Cells · doi:10.3390/cells11091432 · Cited by 25

SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors

Cui, Y., Li, Y., Xu, Y., Liu, X., Kang, X., Zhu, J., Long, S., Han, Y., Xue, C., Sun, Z., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103304 · Cited by 30

Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction

Dahlmanns, M., Yakubov, E., & Dahlmanns, J. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.783067 · Cited by 24

Targeting Nutrient Dependency in Cancer Treatment

Fan, K., Liu, Z., Gao, M., Tu, K., Xu, Q., & Zhang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.820173 · Cited by 26

From DNMT1 degrader to ferroptosis promoter: Drug repositioning of 6-Thioguanine as a ferroptosis inducer in gastric cancer

Zhang, J., Gao, M., Niu, Y., & Sun, J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.03.026 · Cited by 26

Recent advances of ferroptosis in tumor: From biological function to clinical application

Hu, S., Chu, Y., Zhou, X., & Wang, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115419 · Cited by 24

Sulfosalicylic acid/Fe 3+ based nanoscale coordination polymers for effective cancer therapy by the Fenton reaction: an inspiration for understanding the role of aspirin in the prevention of cancer

Liu, Q., Du, K., Liu, M., Lv, R., Sun, B., Cao, D., He, N., & Wang, Z. (2019) · Biomaterials Science · doi:10.1039/c9bm00799g · Cited by 24

An Overview of Therapeutic Targeting of Nrf2 Signaling Pathway in Rheumatoid Arthritis

Saha, S. (2024) · ACS Omega · doi:10.1021/acsomega.4c00163 · Cited by 24

Mechanistic elucidation of ferroptosis and ferritinophagy: implications for advancing our understanding of arthritis

Guo, C., Peng, J., Cheng, P., Yang, C., Gong, S., Zhang, L., Zhang, T., & Peng, J. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1290234 · Cited by 25

Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs

Zhi, Y., Gao, L., Wang, B., Ren, W., Liang, K. X., & Zhi, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.686906 · Cited by 26

Pharmacologic approaches to amino acid depletion for cancer therapy

Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23

The profibrotic and senescence phenotype of old lung fibroblasts is reversed or ameliorated by genetic and pharmacological manipulation of Slc7a11 expression

Ritzenthaler, J. D., Torres-González, E., Zheng, Y., Zelko, I. N., van Berkel, V. H., Nunley, D. R., Kidane, B., Halayko, A. J., Summer, R. S., Watson, W. H., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00593.2020 · Cited by 23

Pancreatic acinar cell fate relies on system xC- to prevent ferroptosis during stress

Pan, Z., den Bossche, J.-L. V., Rodríguez-Aznar, E., Janssen, P., Lara, O., Ates, G., Massie, A., Paep, D. L. D., Houbracken, I., Mambretti, M., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06063-w · Cited by 26

Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches

Wang, J., Guo, D., Jiang, S., Wu, W., & Gao, X. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00416-5 · Cited by 27

Ferroptosis Biology and Implication in Cancers

Qu, C., Peng, Y., & Liu, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.892957 · Cited by 22

Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs

García-Gaytán, A. C., Hernández-Abrego, A., Díaz‐Muñoz, M., & Méndez, I. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1029210 · Cited by 27

Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?

Hajj, S. E., Canabady‐Rochelle, L., & Gaucher, C. (2023) · Molecules · doi:10.3390/molecules28062636 · Cited by 24

Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer

Takayama, T., Kubo, T., Morikawa, A., Morita, T., Nagano, O., & Saya, H. (2016) · Medical Oncology · doi:10.1007/s12032-016-0760-x · Cited by 22

Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis (Review)

Kobayashi, H., Imanaka, S., & Shigetomi, H. (2022) · Oncology Letters · doi:10.3892/ol.2022.13200 · Cited by 21

Pros and cons of NRF2 activation as adjunctive therapy in rheumatoid arthritis

Manda, G., Milanesi, E., Genç, Ş., Niculite, C. M., Neagoe, I. V., Tastan, B., Dragnea, E. M., & Cuadrado, A. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.012 · Cited by 22

Impact of the polymer backbone chemistry on interactions of amino-acid-derived zwitterionic polymers with cells

Leiske, M. N., Geest, B. G. D., & Hoogenboom, R. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.005 · Cited by 21

DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma

Li, Q., Yuan, H., Zhao, G., Ou, D., Zhang, J., Li, S., Li, S., Feng, T., Gu, R., Kou, Q., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116251 · Cited by 20

Prostaglandin D2-ethanolamide induces skin cancer apoptosis by suppressing the activity of cellular antioxidants

Elhassanny, A. E. M., Ladin, D. A., Soliman, E., Albassam, H., Morris, A. J., Kobet, R. A., Thayne, K. A., Burns, C., Danell, A. S., & Dross, R. V. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.03.001 · Cited by 20

Cystine-dependent antiporters buffer against excess intracellular reactive sulfur species-induced stress

Akiyama, M., Unoki, T., Aoki, H., Nishimura, A., Shinkai, Y., Warabi, E., Nishiyama, K., Furumoto, Y., Anzai, N., Akaike, T., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102514 · Cited by 20

Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15

Wang, S., Chang, Y., Liu, T., Huang, K., Fang, W., Li, A. F., Yeh, T., Hung, G., & Lee, H. (2023) · FEBS Journal · doi:10.1111/febs.16992 · Cited by 20

System X−c Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine

Nehser, M., Dark, J., Schweitzer, D., Campbell, M., Zwicker, J. D., Hitt, D. M., Little, H., Diaz-Correa, A., Holley, D. C., Patel, S. A., et al. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02901-6 · Cited by 20

High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells

Thomas, A. G., Sattler, R., TenDyke, K., Loiacono, K. A., Hansen, H. F., Sahni, V., Hashizume, Y., Rojas, C. J., & Slusher, B. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127785 · Cited by 20

xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases

Dai, L., Noverr, M. C., Parsons, C. H., Kaleeba, J. A. R., & Qin, Z. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00120 · Cited by 20

Targeting Ferroptosis in Colorectal Cancer

Liang, X., You, Z., Chen, X., & Li, J. (2022) · Metabolites · doi:10.3390/metabo12080745 · Cited by 20

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach

Zhou, Q., Li, T., Qin, Q., Huang, X., & Wang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1039951 · Cited by 21

Discovery and optimization of 2-(trifluoromethyl)benzimidazole derivatives as novel ferroptosis inducers in vitro and in vivo

Fang, Y., Tan, Q., Zhou, H., Xu, J., & Gu, Q. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114905 · Cited by 19

Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies

Dhas, N. L., Kudarha, R. R., Tıwarı, R., Tiwari, G., Garg, N., Kumar, P., Kulkarni, S., Kulkarni, J., Soman, S., Hegde, A. R., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122629 · Cited by 20

Targeting ferroptosis as a potential prevention and treatment strategy for aging-related diseases

Jiao, T., Chen, Y., Sun, H., & Yang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107370 · Cited by 20

Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities

Tranchese, R. V., Battista, S., Cerchia, L., & Fedele, M. (2024) · Biomolecules · doi:10.3390/biom14111443 · Cited by 20

A small molecule that induces reactive oxygen species via cellular glutathione depletion

Kawamura, T., Kondoh, Y., Muroi, M., Kawatani, M., & Osada, H. (2014) · Biochemical Journal · doi:10.1042/bj20140669 · Cited by 19

Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis

Blaylock, R. L. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.106577 · Cited by 19

Behavioral assessment of acute inhibition of system xc - in rats

Lutgen, V., Resch, J. M., Qualmann, K. J., Raddatz, N. J., Panhans, C. M., Olander, E. M., Kong, L., Choi, S., Mantsch, J. R., & Baker, D. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3612-4 · Cited by 21

Development of a primary microglia screening assay and its use to characterize inhibition of system xc- by erastin and its analogs

Figuera-Losada, M., Thomas, A. G., Stathis, M. J., Stockwell, B. R., Rojas, C. J., & Slusher, B. S. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2016.12.009 · Cited by 18

Ferroptosis in Ischemic Stroke and Related Traditional Chinese Medicines

Ma, R., Sun, X., Liu, Z., Zhang, J., Yang, G., Tian, J., & Wang, Y. (2024) · Molecules · doi:10.3390/molecules29184359 · Cited by 20

Molecular mechanisms and potential implications of ferroptosis, cuproptosis, and disulfidptosis in septic lung injury

Li, J., Liu, H., Shan, Z., Zhong, K., & Liang, Q. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1615264 · Cited by 19

Targeting ferroptosis as a therapeutic strategy for hepatotoxicity

Hemmati, N., Anoush, M., Kiasari, B. A., & Torkamani, A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102137 · Cited by 19

Initial evaluation of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma

Park, S. Y., Mosci, C., Kumar, M., Wardak, M., Koglin, N., Bullich, S., Mueller, A., Berndt, M., Stephens, A. W., Chin, F. T., et al. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00678-2 · Cited by 18

Review of ferroptosis in colorectal cancer: Friends or foes?

Wu, Z., Fang, Z.-X., Hou, Y.-Y., Wu, B., Deng, Y., Wu, H.-T., & Liu, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i3.469 · Cited by 19

Ferroptosis: potential targets and emerging roles in pancreatic diseases

Huang, Z., Ma, Y., Sun, Z., Cheng, L., & Wang, G. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03625-x · Cited by 19

Genomic analysis of xCT-mediated regulatory network: identification of novel targets against AIDS-associated lymphoma

Dai, L., Cao, Y., Chen, Y., Kaleeba, J. A. R., Zabaleta, J., & Qin, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.3710 · Cited by 18

In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors

Pore, N., Jalla, S., Liu, Z., Higgs, B. W., Sorio, C., Scarpa, A., Hollingsworth, R. E., Tice, D. A., & Michelotti, E. F. (2015) · Neoplasia · doi:10.1016/j.neo.2015.05.001 · Cited by 18

The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs

Ensoy, M., Bumin, Z. S., Jama, H. A., & Cansaran‐Duman, D. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220629154418 · Cited by 17

Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

Watanabe, K., Kimura, S., Seki, M., Isobe, T., Kubota, Y., Sekiguchi, M., Sato‐Otsubo, A., Hiwatari, M., Kato, M., Oka, A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02489-2 · Cited by 18

Natural compounds efficacy in complicated diabetes: A new twist impacting ferroptosis

Bao, T., Zhang, X., Xie, W., Wang, Y., Li, X., Tang, C., Yang, Y., Sun, J., Gao, J., Yu, T., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115544 · Cited by 18

POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase

Peng, Y., Zheng, W., Chen, Y., Lei, X., Yang, Z., Yang, Y., Liang, W., Sun, K., Li, G., & Yu, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06618-5 · Cited by 17

Contemporary insights and prospects on ferroptosis in rheumatoid arthritis management

Zhao, H., Dong, Q., Hua, H., Wu, H., & Ao, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1455607 · Cited by 18

Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways

Fazzari, J., Linher‐Melville, K., & Singh, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123042 · Cited by 16

Glutathione inhibits antibody and complement-mediated immunologic cell injury via multiple mechanisms

Zhang, Z., Zhang, X., Fang, X., Niimi, M., Huang, Y., Piao, H., Gao, S., Fan, J., & Yao, J. Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.030 · Cited by 17

Control of amino acid transport into Chinese hamster ovary cells

Geoghegan, D., Arnall, C. L., Hatton, D., Noble‐Longster, J., Sellick, C. A., Senussi, T., & James, D. C. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26794 · Cited by 18

Low Doses of Silver Nanoparticles Selectively Induce Lipid Peroxidation and Proteotoxic Stress in Mesenchymal Subtypes of Triple-Negative Breast Cancer

Snyder, C. M., Rohde, M. M., Fahrenholtz, C. D., Swanner, J. L., Sloop, J. T., Donati, G. L., Furdui, C. M., & Singh, R. N. (2021) · Cancers · doi:10.3390/cancers13164217 · Cited by 18

Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates

Yang, F., Sun, S., Wang, S., Guo, J., Liu, X., Ge, N., & Wang, G. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.1 · Cited by 18

Chemical–physical properties, morphology, and magnetic investigations on new cystine functionalized ultra-small super-paramagnetic iron-oxide nanoparticles

Dolci, S., Ierardi, V., Remškar, M., Jagličić, Z., Pineider, F., Boni, A., Pampaloni, G., Veracini, C. A., & Domenici, V. (2012) · Journal of Materials Science · doi:10.1007/s10853-012-6871-7 · Cited by 17

Sensing of sulfasalazine—Cysteine transporter inhibitor with platinum nanoflowers decorated on carbon nanotubes by electrochemical reduction

Savalia, R., & Chatterjee, S. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.08.126 · Cited by 17

Role of protein disulfide isomerase in mediating sulfasalazine-induced ferroptosis in HT22 cells: The PDI−NOS–NO−ROS/lipid-ROS cascade

Wu, Y., & Zhu, B. T. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110366 · Cited by 16

Cystine/Glutamate Xc – Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione Biosynthesis

Orlowska, K., Fling, R. R., Nault, R., Schilmiller, A. L., & Zacharewski, T. R. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00017 · Cited by 16

xCT/SLC7A11 antiporter function inhibits HIV-1 infection

Rabinowitz, J., Sharifi, H. J., Martin, H., Marchese, A. M., Robek, M. D., Shi, B., Mongin, A. A., & de Noronha, C. M. C. (2021) · Virology · doi:10.1016/j.virol.2021.01.008 · Cited by 17

Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells

KalantarMotamedi, Y., Ejeian, F., Sabouhi, F., Bahmani, L., Nejati, A. S., Bhagwat, A. M., Ahadi, A. M., Tafreshi, A. P., Nasr‐Esfahani, M. H., & Bender, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-91629-x · Cited by 16

Pharmacological Targeting of Ferroptosis in Cancer Treatment

Roushandeh, A. M., Roudkenar, M. H., Valashedi, M. R., Nikoo, A., Najafi-Ghalehlou, N., Tomita, K., Kuwahara, Y., & Sato, T. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009621666211202091523 · Cited by 17

The pharmacologic inhibition of the xc- antioxidant system improves the antitumor efficacy of COX inhibitors in the in vivo model of 3-MCA tumorigenesis

Balza, E., Castellani, P., Delfino, L., Truini, M., & Rubartelli, A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs360 · Cited by 16

In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine

Gout, P. W., Simms, C. R., & Robertson, M. C. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00004 · Cited by 39

Potential use for sulfasalazine in lung cancer therapy

Gout, P. W., Guan, J., Wang, Y., Xue, H., Doxsee, D., Sutcliffe, M., Cutz, J., LeRiche, J., Bebb, G. D., Lam, S. C., et al. (2004) · Cancer Research · Cited by 1

Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells

Gout, P., Kang, Y. J., Buckley, D., Bruchovsky, N., & Buckley, A. (1997) · Leukemia · doi:10.1038/sj.leu.2400739 · Cited by 53

210 Induction of apoptosis in chronic lymphocytic leukaemia by inhibition of NF-kB and novel sulfasalazine analogues

Packham, G., Habens, F., Mel, S. D., Srinivasan, N., Oakley, F., Mann, D. L., Potter, K. N., Stevenson, F. K., & Ganesan, A. (2004) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(04)80218-0

Abstract 1898: Regulation of cysteine supply for survival in hepatocellular carcinoma an breast cancer cell lines

Kim, D. H., & Lee, S. J. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-1898